Matinas BioPharma Investor Presentation Deck

23 LNC-formulated Small Oligos Show Strong Uptake in Innate Immune Cells Support Role in Treating Inflammation Percent of cells with uptake 100 80 60 40 20 O 0.3 63.1 Neutrophils 80 ug/mL LNC 512 ng/mL Cy5-labeled siRNA cargo 99.9 Human Ex-vivo Whole Blood Study 3.8 Time O 70.8 97.5 Monocytes 3 hours 0.2 24 hours COPYRIGHT MATINAS BIOPHARMA 2024 39.9 94.5 mDC 0.0 0.3 pDC 81.6 MATINAS BIOPHARMA

View entire presentation